Wire Stories
Santen Receives FDA Approval for Verkazia� (Cyclosporine Ophthalmic Emulsion) 0.1% for the Treatment of Vernal Keratoconjunctivitis in Children and Adults
EMERYVILLE, Calif.–(BUSINESS WIRE)–Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (hereinafter, Santen), a global company focused exclusively on eye care,...